Entrada Therapeutics Reports Strong Q4 Earnings with a Surprising GAAP EPS Performance
Thursday, 14 March 2024, 06:56
Entrada Therapeutics Q4 Earnings Report
Entrada Therapeutics recently released their Q4 financial results, showcasing a strong performance in both GAAP EPS and revenue.
Key Highlights:
- Positive GAAP EPS: The company achieved a positive GAAP EPS of -$0.29, surpassing analyst expectations by $0.81.
- Revenue Figures: Entrada Therapeutics reported revenue of $41.85 million in the fourth quarter.
- Financial Position: The company holds $352 million in cash, cash equivalents, and marketable securities as of December 31, 2023.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.